Skip to main content
OpenTrials

Clinical trial condition

Postmenopausal Osteoporosis

Explore clinical trials studying Postmenopausal Osteoporosis. Study availability and eligibility vary by location and protocol.

96 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Postmenopausal Osteoporosis trial results

Completed

A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.

NCT06079476

Conditions
Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations
  • Stavya Spine Hospital and Research Institute SSHRI Ahmedabad, Gujarat, India
  • MS Ramaiah Medical College and Hospitals Bangalore, Karnataka, India
  • King Edward Memorial Hospital And Seth Gordhandas Sunderdas Medical College Mumbai, Maharashtra, India
  • Sancheti Institute for Orthopedics and rehabilitation Pune, Maharashtra, India
View Trial Details
Completed

A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosis

NCT04934072

Conditions
Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations
  • Diagnostic Consultative Center Aleksandrovska Sofia, Sofia-Grad, Bulgaria
  • Diagnostic Consultative Center (DCC) 17 - Sofia Sofia, Sofia-Grad, Bulgaria
  • Medical Center N. I. Pirogov Sofia, Sofia-Grad, Bulgaria
  • Medical Center Hipokrat 2000 OOD Haskovo, Bulgaria
View all 76 locations
View Trial Details
Completed

Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis

NCT05087030

Conditions
Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations
  • Miami Clinical Research Miami, Florida, United States
  • Global Health Research Center Miami Lakes, Florida, United States
  • iResearch Atlanta, LLC Decatur, Georgia, United States
  • Excel Clinical Research - Internal Medicine Las Vegas, Nevada, United States
View all 59 locations
View Trial Details
Completed

Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis

NCT01575834

Conditions
Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Laguna Hills, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Sacramento, California, United States
View all 218 locations
View Trial Details

Related conditions